TM6SF2 and metabolic dysfunction-associated steatotic liver disease: Moreover a meta-analysis on genetic studies showed that TM6SF2 rs58542926 is associated with a lower risk of MASLD, while MBOAT7 rs641738 shows no significant association (Xia et al., 2019).